Quotes 5-day view Delayed Euronext Paris
11/23/2020
11/24/2020
11/25/2020
11/26/2020
11/27/2020
Date
84.09(c)
84.21(c)
84.22(c)
85.37(c)
85.21(c)
Last
1 796 901
2 422 873
2 515 815
1 441 766
2 252 811
Volume
-2.05% +0.14% +0.01% +1.37% -0.19% Change
Sales 2020
36 357 M 43 494 M 43 494 M
Net income 2020
11 732 M 14 035 M 14 035 M
Net Debt 2020
7 972 M 9 537 M 9 537 M
P/E ratio 2020
9,15x
Yield 2020
3,75%
Sales 2021
37 829 M 45 255 M 45 255 M
Net income 2021
5 851 M 7 000 M 7 000 M
Net Debt 2021
5 763 M 6 895 M 6 895 M
P/E ratio 2021
17,9x
Yield 2021
3,93%
Capitalization
107 B 128 B 128 B
EV / Sales 2020
3,16x
EV / Sales 2021
2,98x
Nbr of Employees
100 409
Free-Float
89,0%
Sanofi is the largest European pharmaceutical group. Net sales by family of products break down as follows:
- pharmaceutical products (84.1%): for the treatment of cardio-vascular diseases, thrombosis, central nervous system disorders (insomnia, multiple sclerosis, epilepsy), cancers, allergies, etc. Moreover, Sanofi-Aventis markets OTC products and generic drugs;
- human vaccines (15.9%): pediatric vaccines,...
Notations Surperformance© of Sanofi
Trading Rating : Investor Rating :
News in other languages on SANOFI
Analyst Recommendations on SANOFI
SANOFI - 11/19
A trend reversal can be anticipated
BUY
Exclusive: EU eyes COVID vaccine deal with Moderna at less than $25 per dose, says source
Duration :
Auto.
2 months
3 months
6 months
9 months
1 year
2 years
5 years
10 years
Max.
Period :
Day
Week
Technical analysis trends SANOFI
Short Term Mid-Term Long Term Trends Bullish Neutral Neutral
Income Statement Evolution
Please enable JavaScript in your browser's settings to use dynamic charts.
Mean consensus
OUTPERFORM
Number of Analysts
27
Average target price
103,49 €
Last Close Price
85,21 €
Spread / Highest target
38,5%
Spread / Average Target
21,5%
Spread / Lowest Target
-0,25%
Please enable JavaScript in your browser's settings to use dynamic charts.
1st jan. Capitalization (M$)
SANOFI -4.92% 127 702
Canada
Deutschland
France
Schweiz (DE)
United Kingdom
Report
